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Abstract.  We have used immunocytofluorescence tech- 
niques to determine the subcellular distribution of the 
Ca  2+, phospholipid-dependent protein kinase,  protein 
kinase C  (PKC).  Using monoclonal antibodies that are 
specific for Type 3 (or) PKC, we have determined that 
there are least two pools of PKC in normal  rat embryo 
fibroblasts (REF52 cells): diffuse cytoplasmic and 
fiber-associated. Extraction  with chelators and de- 
tergent before fixing and staining  removes the cyto- 
plasmic PKC.  The fiber-associated staining  remains 
in these cytoskeleton preparations.  The cytoskeleton 
Type 3 PKC staining  closely resembles that of the fo- 
cal contact protein vinculin and coiocalizes with an- 
other focal contact protein,  talin.  Cytochalasin,  but not 
colchicine,  coordinately disrupts the staining pattern of 
vinculin and PKC.  Activation of PKC by treatment 
with phorbol esters causes depolymerization of mi- 
crofilaments and reorganization  of vinculin staining. 
We propose that Type 3 PKC is a modulatory compo- 
nent of the focal contact and has a primary role in 
regulation of the association of microfilament bundles 
with the plasma membrane. 
ROTEIN kinase C (PKC)', the Ca  2÷ and phospholipid- 
dependent kinase is recognized to be a key regulatory 
enzyme. Several growth factors and hormones which 
are essential  for normal cell growth and differentiated  func- 
tion regulate the activation state of PKC (26). This is due to 
their ability to stimulate phospholipase C activity, and conse- 
quently,  to increase  cellular diacylglycerol,  an endogenous 
regulator of PKC.  Tumor-promoting  phorbol esters mimic 
diacylglycerol;  they  also  bind  and  activate  PKC  (7,  25). 
Therefore,  prolonged activation  of PKC by phorbol esters, 
which is used in tumor promotion protocols, is thought  to 
play a major role in tumorigenesis.  These data demonstrate 
the importance of PKC both in normal cell function and in 
carcinogenesis. 
These results, which underscore the key regulatory role of 
PKC, have led to efforts to identify substrates  for PKC which 
are relevant to the observed biological responses.  Identifica- 
tion of specific substrates  has been complicated both by the 
demonstration  that  many  proteins  can  serve as PKC  sub- 
strates  in vitro and by the lack of specific PKC inhibitors. 
Furthermore,  because phorbol  esters and  PKC  activation 
have been linked to a wide variety of biological responses, 
it has been difficult to distinguish  between primary and sec- 
ondary effects of PKC action (26). 
PKC is now recognized to be a group of enzymes encoded 
by a family of genes (reviewed in reference 27). If the iso- 
zymes have different substrate specificities, then PKC hetero- 
geneity  may  also  complicate  identification  of PKC  sub- 
strates. Although little data exist to directly compare isozyme 
1.  Abbreviations  used in  this paper:  CSK,  cytoskeleton;  PDBu, phorbol 
dibutyrate; PKC, protein kinase C. 
substrate  specificities,  evidence  for differential  ability  to 
phosphorylate the EGF receptor has been presented (14). 
Subtle differences  in cofactor requirements  among the iso- 
zymes have also been reported (16, 31). However, it is not yet 
known  if biochemical differences  in cofactor requirements 
contribute to differential  isozyme activation.  Clearly,  type- 
specific  reagents,  such  as mAbs,  are required  to address 
questions regarding  the role of individual  isozymes in spe- 
cific biological  processes. 
Using biochemical fractionation techniques,  PKC is found 
in both the soluble and particulate  fractions.  Activation with 
growth factors or hormones causes redistribution  to the par- 
ticulate fraction (11, 19). Presumably, membrane association, 
which implies proximity  with the activating  phospholipids, 
is required for PKC activity (26).  We have considered that 
the primary targets  for phosphorylation by activated  PKC 
would be concentrated  in proximity to the membrane-associ- 
ated PKC. The nature  of the components of the particulate 
fraction  with which  PKC  associates  has not yet been de- 
scribed.  We have,  therefore,  directed  our efforts  towards 
identifying  the membrane association  sites of PKC. 
To accomplish this goal, we have developed highly specific 
mAbs to Type 3 PKC (21), the most widely expressed iso- 
zyme (18). We now report the use of these mAbs for immu- 
nocytochemical  localization of Type 3 PKC. Our results sug- 
gest that there are several pools of Type 3 PKC in normal 
rat embryo fibroblasts  (REF52 cells). A substantial  fraction 
of Type 3  PKC  is  a  component of the focal  contact,  the 
specialized  area of the cytoskeleton  (CSK) that mediates at- 
tachment  of the microfilaments  with the plasma membrane 
(6, 9).  Furthermore,  our results  indicate  that activation  of 
PKC  by  treating  cells  with  phorbol  dibutyrate  (PDBu), 
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appears to be spatially located to phosphorylate proteins that 
are important in regulating CSK structure. 
Materials and Methods 
lmmunochemical Reagents 
All  anti-CSK antibodies were obtained from Sigma Chemical Co.  (St. 
Louis, MO) except for antitubulin which was obtained from Southern Bio- 
technology Associates (Birmingham,  AL).  Rhodamine-conjugated phal- 
Ioidin was purchased from Molecular Probes Inc.  (Junction City,  OR). 
Fluorescein- and rhodamine-conjugated second antibodies were from Cap- 
pel Laboratories (Malvern, PA). Alkaline phosphatase-conjugated antibod- 
ies and substrates were from Promega Biotec (Madison, WI). Rabbit anti- 
talin antibody was a gift of Dr. Keith Burridge (Chapel Hill, NC). 
Other Reagents 
Cytochalasin B, colchicine, and PDBu were all from Sigma Chemical Co. 
Triton X-100, Afli-gel 10, and protein assay reagents were from Bio-Rad 
Laboratories (Richmond, CA). All other reagents were of the highest qual- 
ity available. 
Cell Culture 
Rat embryo fibroblasts (REF52 cells) were used between passage 10 and 
20. Cells were grown in a  1:3 mixture of Ham's F-12 and DME containing 
10% FBS. REF52 cells were originally obtained from Dr. D. B. McClure 
(Eli Lilly and Co., Indianapolis, IN). 
Antibodies to PKC 
The preparation and properties of the anti-Type 3 PKC mAb M6 used in 
these studies are described in reference 21. This mAb is specific for Type 
3 PKC; it does not recognize Type 1 or 2 PKC. The epitope recognized is 
within the catalytic domain. 
Preparation of CSKs 
Cells grown on coverslips were washed twice in  modified microtubule 
stabilization buffer without GTP and with glycerol instead of polyethylene- 
glycol as described by Osborn and Weber (28).  Soluble proteins were ex- 
tracted during a 5-rain incubation in microtubule stabilization buffer con- 
taining 0.2%  Triton X-100,  10/tg/ml  leupeptin, and  10 ttg/ml agrotinin. 
After washing twice in microtubule stabilization buffer, samples were fixed 
and stained as described for whole cells. 
lmmunofluorescence Protocol 
Cells were grown on 12-ram glass coverslips. Cells or CSKs were washed 
twice with PBS, then fixed for 10 min at room temperature in 4% formalde- 
hyde in PBS. After washing twice with PBS, cells were permeabilized for 
5 rain in PBS containing 0.2% TritonX-100 and finally washed twice with 
PBS. Staining was performed by incubating for 1 h in first antibody diluted 
in  PBS containing  10  mg/ml  BSA (PBA),  washing,  then incubating in 
rhodamine-  or  fluorescein-conjugated second antibody diluted  in  PBA 
(1:300) for I h. M6 was used at a 1:20 dilution. Rhodamine-conjugated phal- 
Ioidin was used at 1:40 dilution in PBA. Coverslips were viewed on a Zeiss 
Axioplan microscope with a 63 x  objective. Photomicrographs were taken 
on Kodak T  Max 400 film using 8-15-s exposure times for PKC stained 
samples. 
Immunoblot Analysis 
CSKs were prepared from cells grown in 35-ram dishes as described above. 
CSK protein, which remained on the dish, was collected by scraping into 
PAPA (50 mM Tris-Cl, pH 7.4, 0.15 M NaCI,  1 mM EDTA, 1% deoxycho- 
late, 1% Triton X-100, and 0.1% SDS). Protein from both the soluble and 
CSK fractions was precipitated with chloroform and methanol as described 
by Wessel and Fliigge (33). Samples were resuspended in 80 ml of Laemmli 
sample preparation buffer (20 containing 5 % fl-mercaptoethanol for SDS- 
PAGE and subsequent transfer to nitrocellulose. Equal aliquots (30 td) were 
applied to the gel. Immunoblots were blocked with 5% instant nonfat milk 
in TBS (50 mM Tris-CI containing 0.5 M NaCI), incubated in M6 diluted 
in TBA (TBS containing 1% BSA), and finally in alkaline phosphatase-con- 
jugated goat anti-mouse lgG diluted in TBA. At least tv~ washes in TBS 
were included between each incubation. Color was developed according to 
the manufacturer's procedures. 
Preparation of  PKC-absorbed Antibody Solution 
PKC was purified as described (16) with the addition of a phenyI-Sepharose 
column. Approximately 5 mg of PKC isozyme mixture of >90% purity was 
coupled to Afli-gel 10 according to the manufacturer's instructions. Condi- 
tioned medium from the hybridoma culture was concentrated by ammonium 
sulfate,  dialyzed against  PBS,  and  applied  to  the  PKC-aflinity column 
equilibrated in PBS. The column flow through was collected. The starting 
material was diluted to adjust the protein concentration to that of the nonad- 
sorbed column flow through. We verified that the column flow through was 
depleted of anti-PKC mAb relative to the starting material by dot blots with 
purified Type 3 PKC. Protein was measured by the method of Bradford (3). 
Results 
l~pe 3 PKC lmmunofluorescence in Whole Cells 
and CSKs 
Subconfluent  REF52 cells were fixed, permeabilized, stained 
with the anti-catalytic  domain, Type 3 PKC specifc mAb 
M6 and finally, with fluorescein-conjugated second antibody 
(Fig.  1). Diffuse cytoplasmic as well as nuclear staining  was 
apparent.  Some of the extranuclear  staining appeared to line 
up on fibers in an arrowhead pattern.  The specificity of the 
staining  was demonstrated  in several  ways.  First,  fluores- 
cence was diminished if M6 was omitted. Some nuclear stain- 
ing  was  observed  in  these  minus  M6  controls,  however. 
Therefore,  although  nuclear  staining  appears  brighter  in 
samples incubated  with M6, it is difficult for us to evaluate 
specific nuclear staining in these preparations.  Second, fluo- 
rescence was greatly  diminished if the M6 solution was first 
passed over a PKC affinity  column. Third, immunoblots of 
cell lysates stained with M6 revealed only one major immu- 
noreactive band of 82 kD which comigrated with purified 
brain Type 3 PKC (data not shown, but see Fig. 3). 
The fiber-associated staining pattern suggested that some 
of the Type 3 PKC may be associated with CSK components. 
We, therefore, prepared CSKs by extracting soluble compo- 
nents with chelator and detergent. The CSKs were then fixed 
and stained as described for whole cells. The diffuse back- 
ground fluorescence observed in whole cells is not apparent 
in the CSK preparations  (Fig.  2).  However,  much of the 
fiber-associated staining remains. 
We used immunoblots to identify the immunoreactive spe- 
cies associated with the CSKs (Fig. 3). Both the soluble and 
CSK fractions contained mainly 82-kD PKC as the major 
immunoreactive species.  A  higher molecular mass cross- 
reactive  species  was  also  found  in  the  soluble  fraction. 
Pretreatment of the cells with PDBu for 10 min before prepa- 
ration of the CSKs did not substantially alter the distribution 
of Type 3 PKC between the soluble and CSK fractions. 
Comparison of  PKC Staining with CSK Protein 
Staining Patterns 
To determine to what CSK compartment PKC is associated, 
we compared the PKC  staining pattern  to that of known 
CSK proteins using available antisera. Type 3 PKC staining 
was decidedly different from the microfilament staining ob- 
served with phalloidin, the intermediate filament staining 
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The first antibodies  used were as follows: A, M6; B, minus first antibody control;  C, PKC-absorbed  M6 control. 
observed with  antivimentin,  and  the  microtubule  staining 
observed with antitubulin  (Fig.  4).  PKC staining  was also 
different from that of the actin-binding proteins a-actinin, 
spectrin,  filamin, and tropomyosin. However, Type 3  PKC 
staining was very similar to that of the focal contact protein, 
vinculin.  Double immunofluorescence with M6 and rabbit 
antibody to another focal contact protein, talin (5) demon- 
strates that staining patterns for Type 3 PKC and talin within 
the same cell are very similar (Fig. 5). In both cases, short 
strips  of intense  fluorescence  were  found  throughout  the 
cytoplasm. Nuclear staining is much more apparent with M6 
than with vinculin or talin. 
The similarity in distribution of PKC with vinculin and ta- 
lin indicates that PKC is also a component of the focal con- 
tact. In addition to its localization in the focal contact, talin 
has also been reported in ruffling membranes and at the lead- 
ing edges of cells (5).  It is therefore,  possible that Type 3 
PKC may also be found in other CSK structures.  Some evi- 
dence for this can be seen in Fig.  5  (top)  in  which  fibrils 
Figure 2. Type 3 PKC immunofluorescence in CSKs. Whole cells 
(A) or CSKs (B) were fixed and stained with M6. 
l~gure 3. Immunoblot of REF- 
52 cell fractions.  Preparation 
of samples  and  immunoblot- 
ting  protocol  is  described  in 
Materials and Methods. Where 
indicated,  cells  were  treated 
with PDBu (100 ng/ml) for 10 
min at 37 °. The soluble (SOL) 
and  cytoskeletal  (CSK)  frac- 
tions  from  control  (-)  and 
PDBu-treated  (+)  cultures 
were analyzed with M6. 
Jaken et al. lmr~unocytochemical  Localization of PKC  699 Figure 4. Immunofluorescence of 
CSK  proteins  in  REF52  cells. 
CSKs were prepared,  fixed, and 
stained as described in Materials 
and Methods. The first antibodies 
were directed against the follow- 
ing proteins: A, vinculin; B, oeac- 
tinin; C, spectrin; D, vimentin; E 
tropomyosin; G, filamin; H, Tu- 
bulin. In E, the CSKs were stained 
with rhodamine-phalloidin. 
staining for both PKC and talin appear to be above the nu- 
cleus, and therefore, cannot be at the substrate adhesion site. 
Effects of CSK-aitering Drugs on ~pe 3 PKC Staining 
REF52 cells were treated with drugs that depolymerize spe- 
cific CSK filaments to determine if PKC  is directly asso- 
ciated with microfilaments or microtubules (Fig.  5).  Col- 
chicine caused  depolymerization of microtubules  without 
affecting the  microfilaments (as  observed with  phalloidin 
staining). Colchicine did not significantly affect either PKC 
or vinculin staining. This demonstrates that PKC in the CSK 
is not associated with microtubules. 
Treatment of REF52  cells  with  cytochalasin  B  caused 
marked disruption of microfilaments without disturbing mi- 
crotubules (Fig. 6). Cytochalasin decreased the quantity and 
size of the stress fibers observed with phalloidin. In addition, 
some completely depolymerized actin dots were found. Cy- 
tochalasin also changed vinculin and PKC staining patterns. 
In both cases,  the fiber-associated staining was lost.  Very 
short, thin, and disordered remnants of the fibers could be 
seen throughout the cytoplasm. An intense staining at the rim 
of the cells was also observed. The coordinate changes in 
vinculin and PKC staining with cytochalasin-treatment indi- 
cate that PKC and vinculin share a common subcellular lo- 
calization. 
Effects of  Phorbol-Ester Treatment on Fluorescent 
Staining Patterns 
The similar staining patterns observed for Type 3 PKC and 
the focal contact proteins, vinculin and talin, along with the 
The Journal of Cell Biology, Volume 109,  1989  700 Figure 5. Colocalization  of ot-PKC and talin in REF52 cells. CSKs were prepared,  fixed, and stained as described in Materials and Methods. 
Preparations were sequentially incubated with M6, rabbit antiserum to talin, and a mixture of TRITC-conjugated anti-rabbit and FITC- 
conjugated  anti-mouse antibodies. Bar,  16 #m. 
Figure 6.  Effect of CSK-interacting  drugs on PKC and vinculin staining patterns.  Cells were treated with nothing (control), cytochalasin 
B (1 #g/ml), or colchicine (1 #g/ml) for  18 h. CSKs were then prepared,  fixed, and stained as described in Materials  and Methods. 
Jaken et al. lmmunocytochemical  Localization of PKC  701 Figure 7. Effect of PDBu on PKC, vinculin, and microfilaments. Cells were treated without or with PDBu (100 ng/ml) for 10 min at 37°C. 
CSKs were prepared, fixed, and stained as described in Materials and Methods. Similar effects were observed in whole cell preparations. 
cytochalasin experiments  indicate  that  PKC  is  associated 
with  focal  contacts.  Consequently,  activation of PKC  by 
treating cells with phorbol esters might lead to phosphoryla- 
tion events that are important for regulating focal contact 
and/or microfilament structure. In fact, treatment of REF52 
cells with PDBu causes a rapid depolymerization of micro- 
filaments (Fig. 7). Actin bundles are less numerous and thin- 
ner. In some areas, complete depolymerization is seen.  In 
PDBu-treated cells, vinculin staining in the cell interior is as- 
sociated with shorter fibers and becomes disorganized. The 
staining no longer lines up in a parallel pattern. Effects on 
staining at the cell periphery are not as readily apparent. In 
PDBu-treated cells, changes in PKC staining paralleled those 
observed for vinculin. 
Discussion 
Cellular mechanisms  for regulating the activation state of 
PKC  are not clearly understood.  In  resting cells,  PKC  is 
found largely in the soluble fraction. Activation of PKC is 
associated with redistribution to the insoluble fraction (19). 
The insoluble components with which PKC associates are 
undefined. Several lines of evidence suggest that interaction 
of PKC with the CSK is a likely candidate for regulating the 
partitioning of PKC  between soluble and  pelletable frac- 
tions. First, many CSK proteins are known to be good PKC 
substrates. These include several proteins associated with the 
actin cytoskeleton such as vinculin (32), filamin (17), profilin 
(12), and red cell band 4.1 (23). Phosphorylation of  the inter- 
mediate filament protein, desmin, by PKC inhibits its ability 
to  polymerize (15).  Phosphorylation of the  microtubule- 
associated protein MAP2 by PKC reduced its ability to inter- 
act with actin (1). PKC activation has also been associated 
with phosphorylation of  the nuclear membrane protein, lam- 
in B  (8,  13).  Second, phorbol esters cause morphological 
changes, which are likely a consequence of effects on CSK 
organization, in a variety of cells. Third, using biochemical 
techniques, Papadapoulos et al. demonstrated that PKC mem- 
brane  association  is  chelator-  and  detergent-stable  (27a). 
These are conditions similar to those we have used to prepare 
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evidence that PKC may associate with detergent-insoluble 
CSK proteins using an overlay technique (34).  We have ex- 
tended these results using immunocytochemical techniques 
to demonstrate that the most widely expressed PKC isozyme, 
Type 3 (c0, is in the CSK of REF52 cells. Furthermore, we 
were able to determine that a substantial portion of Type 3 
PKC is concentrated in the specialized area of the CSK known 
as the focal contact." 
Focal contacts are  the  specialized area of the cell that 
mediate attachment to the extracellular matrix (for reviews, 
see references 6 and 9). In this region, several proteins, in- 
cluding vinculin, talin, integrin, and c~ actinin mediate the 
attachment of microfilament bundles to the plasma mem- 
brane. Several less abundant proteins which may serve regu- 
latory functions, have also been localized to this area, includ- 
ing calpain II (2) and the tyrosine kinases pp60src (29), p120 
gag-abl (30), and p90 gag-yes (10). In addition, immunocy- 
tochemical  studies  using  anti-phosphotyrosine antibodies 
indicate that tyrosine-phosphorylated proteins are also en- 
riched in this area (24). Our data demonstrate that PKC Type 
3  is also found in this region.  Taken together, these data 
strongly suggest that the focal contact is not merely a struc- 
tural link between the CSK, plasma membrane, and the ex- 
tracellular matrix. Instead it appears to be a highly dynamic 
structure which functions in communication between the cell 
and the extracellular environment. 
Vinculin, talin, and integrin play a functional role in at- 
tachment of microfilament bundles to the plasma membrane 
(6). There is evidence that each of these may be a PKC sub- 
strate (4, 6, 32). Our data demonstrate that one consequence 
of PKC activation in these cells involves reorganization of 
vinculin and depolymerization of actin.  Our working hy- 
pothesis to explain these results is that PKC is a regulatory 
component of the focal contact. In resting cells, PKC is inac- 
tive. Upon stimulation with phorbol ester, PKC is activated 
and phosphorylates proteins that are important for stabiliza- 
tion of the microfilament-membrane interaction. This leads 
to depolymerization of the actin filaments, as well as deterio- 
ration of the adhesion plaque. This model allows us to postu- 
late that proteins that mediate plasma membrane association 
of microfilaments are important PKC substrates, and allows 
us to design experimental approaches to determine which of 
these may be the primary targets for Type 3 PKC phosphory- 
lation  events.  More  importantly,  these  results  provide  a 
framework for understanding the multitude of phorbol es- 
ter-directed  responses  including changes  in  morphology, 
CSK organization, and adhesiveness (26). 
Our data indicate that other pools of Type 3 PKC are also 
present in REF52 cells. In the accompanying article in which 
we have studied Type 3 PKC localization in 3T3 cells (22), 
several pools were also apparent including diffuse cytoplas- 
mic, CSK, and nuclear. Because both studies used highly 
specific mAbs to Type 3 PKC, a direct comparison of the two 
cell types can be made, That is, our analysis is not compli- 
cated by the possibility that the mAbs are recognizing differ- 
ent PKC types in different cell lines. In 3T3 cells, the striking 
focal contact pattern observed in REF52 cells was not readily 
apparent. This difference may in part be due to the remark- 
ably well-organized CSK characteristic of the REF52 cells. 
Consequently, the concentration of Type 3 PKC in the focal 
contact may be easier to discern in these cells compared with 
others. The most notable feature of Type 3 PKC staining in 
the 3T3 cells was the redistribution to the nuclear envelope 
after phorbol ester treatment. This was not as readily ob- 
served in the REF52 cells. These differences indicate that 
Type 3 PKC has the potential for several different subcellular 
locations, and that individual cell type characteristics may 
influence the distribution. Such differences might stem from 
differences in the cellular Type 3 PKCs themselves, or to 
differences in the abundance of proteins with which Type 3 
PKC associates. Further studies will address these issues. 
We have demonstrated PKC localization in focal contacts 
of REF52 cells and the nuclear envelope of 3T3 cells (22). 
In spite of the specific differences, there is an underlying 
general theme in that Type 3 PKC is associated with CSK 
components in each cell line.  More significantly, in each 
case, the association is with CSK structures that are of con- 
siderable importance in signal transduction and gene expres- 
sion. In the REF52 cells, we demonstrated an effect of PKC 
activation by PDBu on focal contact structure. If we may ex- 
trapolate from focal contacts a similar function for PKC in 
other subcellular locations, we may suggest that Type 3 PKC 
may also function in regulating the association of other CSK 
filaments with other membranes, including the nuclear mem- 
brane. Higher resolution such as that obtained with the elec- 
tron microscope will be used to address these issues. 
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